Form 8-K - Current report:
SEC Accession No. 0001193125-24-286169
Filing Date
2024-12-30
Accepted
2024-12-30 06:04:51
Documents
14
Period of Report
2024-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917390d8k.htm   iXBRL 8-K 27156
2 EX-99.1 d917390dex991.htm EX-99.1 13864
  Complete submission text file 0001193125-24-286169.txt   169325

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idya-20241227.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20241227_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20241227_pre.xml EX-101.PRE 11267
16 EXTRACTED XBRL INSTANCE DOCUMENT d917390d8k_htm.xml XML 3652
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 241586858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)